AEON Biopharma, Inc. (AEON) Ownership
AEON ownership summary
as of October 18, 2026- Institutions
- 32.8% of shares outstanding
- Insiders
- 54.98% of shares outstanding
- Shares outstanding
- 49.9M
- Float
- 24.0M shares available to trade
- Short interest
- 5.78% 2.2M shares short
- Days to cover
- 0.13 short interest up 19.9% vs prior month
- Institutions 32.77%
- Insiders 54.98%
- Other investors 12.24%
AEON insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | Jost Fischer | Buy | $0.51 | 60,000 | $30,600 |
| 2025-05-19 | Jost Fischer | Buy | $0.50 | 50,000 | $25,000 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
AEON shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AEON
Institutional investors own 32.8% of AEON Biopharma's shares and insiders 54.98%. Short interest is 5.78% of the float, or 0.13 days of average trading volume. The share count rose 527.8% since 2022.
Related: AEON analyst forecast, AEON key metrics. See the AEON stock overview for the latest quote and news.
AEON ownership FAQ
What percentage of AEON Biopharma is owned by institutions?
Institutions hold 32.8% of AEON Biopharma's shares outstanding; insiders hold 54.98%.
What is AEON Biopharma's short interest?
2.2M shares of AEON Biopharma were sold short, 5.78% of the float; at the average daily volume it would take 0.13 days to cover.
Are insiders buying or selling AEON Biopharma?
Of the latest 2 reported insider transactions in AEON Biopharma (since May 19, 2025), 2 were purchases and 0 were sales.
How many shares of AEON Biopharma are outstanding?
AEON Biopharma has 49.9M shares outstanding, of which 24.0M are in the public float.